Bill > A00692

This bill makes technical changes to existing provisions of the New York Public Health Law related to epinephrine auto-injector devices in places of public assembly. Specifically, the bill reletters an existing subdivision from 5-d to 5-e and adjusts related cross-references to ensure legal consistency. The bill modifies the effective date of the underlying law, changing it from taking effect immediately to taking effect nine months after becoming law. Additionally, the bill allows for the preparation and authorization of necessary rules and regulations in advance of the law's full implementation. The changes appear to be primarily administrative in nature, ensuring smooth implementation of requirements that places of public assembly have functional epinephrine auto-injectors (commonly known as EpiPens) available and have at least one trained employee or volunteer present who knows how to use them. An epinephrine auto-injector is a medical device used to treat severe allergic reactions (anaphylaxis) by quickly delivering a dose of epinephrine to counteract potentially life-threatening symptoms.

Health and Social Services

https://www.nysenate.gov/legislation/bills/2025/A692